<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05793567</url>
  </required_header>
  <id_info>
    <org_study_id>22-012721</org_study_id>
    <nct_id>NCT05793567</nct_id>
  </id_info>
  <brief_title>A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)</brief_title>
  <official_title>Assessment of Microcirculatory Function in Type 2 Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to find out if patients with Type 2 Myocardial Infarction&#xD;
      (T2MI) without significant epicardial coronary artery disease (CAD) have a greater chance of&#xD;
      having coronary microvascular disease (CMD).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2023</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary Flow Reserve (CFR)</measure>
    <time_frame>Baseline</time_frame>
    <description>The CFR will be calculated as a ratio of coronary flow at peak hyperemia /coronary flow at rest.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Backward Compression Wave (BCW)</measure>
    <time_frame>Baseline</time_frame>
    <description>The BCW is a measure of increased microvascular resistance during systole.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Coronary Microvascular Disease</condition>
  <arm_group>
    <arm_group_label>T2MI Patients</arm_group_label>
    <description>Patients with T2MI and no epicardial coronary stenosis &gt;50% will be prospectively enrolled and undergo a routine standard of care coronary angiogram with coronary reactivity testing (CRT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Patients with atypical chest pain and no obstructive disease on coronary angiogram who have been referred for investigation of suspected CMD and have a clinical indication for CMD testing will be retrospectively enrolled and data collected from a previous routine standard of care coronary angiogram with coronary reactivity testing (CRT) will be utilized.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Coronary angiogram with coronary reactivity testing (CRT)</intervention_name>
    <description>CRT is an angiography procedure (using X-ray) to examine the small blood vessels in the heart and how they respond to three drugs (adenosine, acetylcholine and nitroglycerin) as per clinical protocol.</description>
    <arm_group_label>T2MI Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects receiving care at Mayo Clinic in Rochester, MN identified with T2MI and controls&#xD;
        with atypical chest pain with indication for CMD testing will be enrolled in this study.&#xD;
        Both groups will have no epicardial coronary stenosis &gt;50% or obstructive disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
          -  Structurally normal heart (normal LV and RV function, no more than mild valvular heart&#xD;
             disease)&#xD;
&#xD;
          -  For controls: atypical chest pain with indication for CMD testing&#xD;
&#xD;
          -  For T2MI: meet criteria for T2MI according to the 4th Universal definition of MI&#xD;
             (rise/fall of troponin with at least 1 value &gt;99th centile+ evidence of symptoms or&#xD;
             signs of myocardial ischemia)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute coronary event (evidence of plaque rupture, fissure or dissection on coronary&#xD;
             angiogram)&#xD;
&#xD;
          -  Known to have angiographically significant CAD/pressure wire positive for epicardial&#xD;
             CAD&#xD;
&#xD;
          -  Inability to receive heparin products&#xD;
&#xD;
          -  Allergy/contraindication to acetylcholine/adenosine/nitroglycerine products&#xD;
&#xD;
          -  Prior coronary artery bypass grafting&#xD;
&#xD;
          -  Pregnancy (if sexually active woman of reproductive age, need negative pregnancy test&#xD;
             prior to proceeding with coronary angiography - this is standard of care in cath lab)&#xD;
&#xD;
          -  Asthma with prior ICU admission due to bronchospasm/need for invasive ventilation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Raphael, MBBS, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ischemic Heart Disease Research Team</last_name>
    <phone>507-255-1724</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire Raphael, MBBS, PhD</last_name>
    <phone>507-255-2445</phone>
    <email>Raphael.Claire@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Ischemic Heart Disease Research Team</last_name>
      <phone>507-255-1724</phone>
    </contact>
    <contact_backup>
      <last_name>Claire Raphael, MBBS, PhD</last_name>
      <phone>507-255-2445</phone>
      <email>Raphael.Claire@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Claire Raphael, MBBS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>March 20, 2023</study_first_submitted>
  <study_first_submitted_qc>March 30, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2023</study_first_posted>
  <last_update_submitted>May 8, 2023</last_update_submitted>
  <last_update_submitted_qc>May 8, 2023</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Claire E. Raphael</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Microvascular Angina</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

